Stay updated on Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now presents the full MOR106 Phase 1 study record, including its termination for futility, study design, participant criteria, locations, and measures, instead of a 403 error page.
    Difference
    66%
    Check dated 2026-11-08T15:14:28.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page no longer displays the 403 error and instead shows the ClinicalTrials.gov site shell, with the revision updated to v3.8.0. The study details are not visible in the new page view.
    Difference
    0.6%
    Check dated 2026-11-01T16:25:41.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A notice banner was added announcing NIH website transition updates and saying that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T19:25:37.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:32:36.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T22:33:48.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A 403 Forbidden error now appears on the page, replacing the previous study record content with an error screen. This prevents users from viewing the study details, locations, and related information on the page.
    Difference
    20%
    Check dated 2026-09-20T20:51:51.000Z thumbnail image

Stay in the know with updates to Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.